This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yauch, L. E.
Right arrow Articles by Levitz, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yauch, L. E.
Right arrow Articles by Levitz, S. M.

 Previous Article  |  Next Article 

Infection and Immunity, December 2005, p. 8429-8432, Vol. 73, No. 12
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.12.8429-8432.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Receptor-Mediated Clearance of Cryptococcus neoformans Capsular Polysaccharide In Vivo

Lauren E. Yauch, Michael K. Mansour,{dagger} and Stuart M. Levitz*

Departments of Medicine and Microbiology, Boston University School of Medicine, Boston, Massachusetts 02118

Received 13 July 2005/ Returned for modification 9 August 2005/ Accepted 26 August 2005

Cryptococcus neoformans capsular glucuronoxylomannan (GXM) is shed during cryptococcosis and taken up by macrophages. The roles of the putative GXM receptors CD14, CD18, Toll-like receptor 2 (TLR2), and TLR4 in GXM clearance from serum and deposition in the liver and spleen in receptor-deficient mice were studied. While alterations in the kinetics of GXM redistribution were seen in the mutant mice, none of the receptors was absolutely required for serum clearance or hepatosplenic accumulation.

* Corresponding author. Mailing address: Section of Infectious Diseases, 650 Albany St., Boston University Medical Center, Boston, MA02118. Phone: (617) 638-7904. Fax: (617) 638-7923. E-mail: slevitz{at}bu.edu.

Editor: A. Casadevall

{dagger} Present address: Department of Medicine, Massachusetts General Hospital, Gray Bigelow 740, 55 Fruit Street, Boston, MA 02114.

Infection and Immunity, December 2005, p. 8429-8432, Vol. 73, No. 12
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.12.8429-8432.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Means, T. K., Mylonakis, E., Tampakakis, E., Colvin, R. A., Seung, E., Puckett, L., Tai, M. F., Stewart, C. R., Pukkila-Worley, R., Hickman, S. E., Moore, K. J., Calderwood, S. B., Hacohen, N., Luster, A. D., El Khoury, J. (2009). Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. JEM 206: 637-653 [Abstract] [Full Text]  
  • Regueiro, V., Moranta, D., Campos, M. A., Margareto, J., Garmendia, J., Bengoechea, J. A. (2009). Klebsiella pneumoniae Increases the Levels of Toll-Like Receptors 2 and 4 in Human Airway Epithelial Cells. Infect. Immun. 77: 714-724 [Abstract] [Full Text]  
  • Chiapello, L. S., Baronetti, J. L., Garro, A. P., Spesso, M. F., Masih, D. T. (2008). Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway. Int Immunol 20: 1527-1541 [Abstract] [Full Text]  
  • Datta, K., Lees, A., Pirofski, L.-a. (2008). Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan. CVI 15: 1176-1187 [Abstract] [Full Text]  
  • Kreisman, L. S.C., Friedman, J. H., Neaga, A., Cobb, B. A. (2007). Structure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism. Glycobiology 17: 46-55 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»